BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 28444172)

  • 1. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study.
    Ogdie A; Kay McGill N; Shin DB; Takeshita J; Jon Love T; Noe MH; Chiesa Fuxench ZC; Choi HK; Mehta NN; Gelfand JM
    Eur Heart J; 2018 Oct; 39(39):3608-3614. PubMed ID: 28444172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study.
    Ogdie A; Yu Y; Haynes K; Love TJ; Maliha S; Jiang Y; Troxel AB; Hennessy S; Kimmel SE; Margolis DJ; Choi H; Mehta NN; Gelfand JM
    Ann Rheum Dis; 2015 Feb; 74(2):326-32. PubMed ID: 25351522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study.
    Ogdie A; Haynes K; Troxel AB; Love TJ; Hennessy S; Choi H; Gelfand JM
    Ann Rheum Dis; 2014 Jan; 73(1):149-53. PubMed ID: 23264338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.
    Mease P; Charles-Schoeman C; Cohen S; Fallon L; Woolcott J; Yun H; Kremer J; Greenberg J; Malley W; Onofrei A; Kanik KS; Graham D; Wang C; Connell C; Valdez H; Hauben M; Hung E; Madsen A; Jones TV; Curtis JR
    Ann Rheum Dis; 2020 Nov; 79(11):1400-1413. PubMed ID: 32759265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study.
    Li L; Lu N; Avina-Galindo AM; Zheng Y; Lacaille D; Esdaile JM; Choi HK; Aviña-Zubieta JA
    Rheumatology (Oxford); 2021 Jan; 60(1):188-195. PubMed ID: 32617563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between psoriatic arthritis and venous thromboembolism: a population-based cohort study.
    Gazitt T; Pesachov J; Lavi I; Elias M; Haddad A; Feldhamer I; Cohen AD; Saliba W; Zisman D
    Arthritis Res Ther; 2022 Jan; 24(1):16. PubMed ID: 34996505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study.
    Dubreuil M; Rho YH; Man A; Zhu Y; Zhang Y; Love TJ; Ogdie A; Gelfand JM; Choi HK
    Rheumatology (Oxford); 2014 Feb; 53(2):346-52. PubMed ID: 24185762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence and risk factors for venous thromboembolic events in patients with psoriasis and psoriatic arthritis.
    Damian AC; Colaco K; Rohekar S; Boyd T; Chandran V; Gladman DD; Cook R; Eder L
    Semin Arthritis Rheum; 2021 Jun; 51(3):547-552. PubMed ID: 33895651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis.
    Cooksey R; Brophy S; Kennedy J; Gutierrez FF; Pickles T; Davies R; Piguet V; Choy E
    Semin Arthritis Rheum; 2018 Dec; 48(3):367-373. PubMed ID: 29656791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study.
    Ogdie A; Grewal SK; Noe MH; Shin DB; Takeshita J; Chiesa Fuxench ZC; Carr RM; Gelfand JM
    J Invest Dermatol; 2018 Apr; 138(4):760-767. PubMed ID: 29104161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
    Charles-Schoeman C; Choy E; McInnes IB; Mysler E; Nash P; Yamaoka K; Lippe R; Khan N; Shmagel AK; Palac H; Suboticki J; Curtis JR
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 37945286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting.
    Liang H; Danwada R; Guo D; Curtis JR; Kilpatrick RD; Hendrickson B; Islam SS
    RMD Open; 2019; 5(2):e001013. PubMed ID: 31673413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of venous thromboembolism in patients with rheumatoid arthritis.
    Kim SC; Schneeweiss S; Liu J; Solomon DH
    Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1600-7. PubMed ID: 23666917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study.
    Jafri K; Bartels CM; Shin D; Gelfand JM; Ogdie A
    Arthritis Care Res (Hoboken); 2017 Jan; 69(1):51-57. PubMed ID: 27696731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical trauma recorded in primary care is associated with the onset of psoriatic arthritis among patients with psoriasis.
    Thorarensen SM; Lu N; Ogdie A; Gelfand JM; Choi HK; Love TJ
    Ann Rheum Dis; 2017 Mar; 76(3):521-525. PubMed ID: 27457510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis.
    Solomon DH; Love TJ; Canning C; Schneeweiss S
    Ann Rheum Dis; 2010 Dec; 69(12):2114-7. PubMed ID: 20584807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism risk is lower in patients with atopic dermatitis than other immune-mediated inflammatory diseases: A retrospective, observational, comparative cohort study using US claims data.
    Merola JF; Ertmer B; Liang H; Yue X; Ofori S; Krueger W
    J Am Acad Dermatol; 2024 May; 90(5):935-944. PubMed ID: 38147900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study.
    Ogdie A; Harter L; Shin D; Baker J; Takeshita J; Choi HK; Love TJ; Gelfand JM
    Ann Rheum Dis; 2017 May; 76(5):882-885. PubMed ID: 28093419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of venous thromboembolism in immune-mediated inflammatory diseases: a UK matched cohort study.
    Galloway J; Barrett K; Irving P; Khavandi K; Nijher M; Nicholson R; de Lusignan S; Buch MH
    RMD Open; 2020 Sep; 6(3):. PubMed ID: 32994362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of venous thromboembolism in rheumatoid arthritis.
    Ketfi C; Boutigny A; Mohamedi N; Bouajil S; Magnan B; Amah G; Dillinger JG
    Joint Bone Spine; 2021 May; 88(3):105122. PubMed ID: 33346109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.